AbCellera Biologics Inc.
ABCL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$57 | -$35 | -$46 | -$34 |
| Dep. & Amort. | $7 | $7 | $7 | -$18 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $14 | $14 | $15 | $15 |
| Change in WC | -$18 | -$17 | $10 | -$16 |
| Other Non-Cash | $2 | -$2 | $2 | $45 |
| Operating Cash Flow | -$53 | -$32 | -$12 | -$8 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9 | -$13 | -$11 | -$16 |
| Net Acquisitions | -$2 | -$3 | $0 | $0 |
| Inv. Purchases | -$36 | -$135 | -$165 | $0 |
| Inv. Sales/Matur. | $83 | $113 | $0 | $0 |
| Other Inv. Act. | $1 | $5 | $184 | $51 |
| Investing Cash Flow | $36 | -$32 | $8 | $36 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $6 | $6 | $6 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | -$2 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $7 | -$9 | -$0 | -$0 |
| Financing Cash Flow | $7 | -$3 | $6 | $4 |
| Forex Effect | -$1 | $1 | $1 | -$2 |
| Net Chg. in Cash | -$9 | -$67 | $3 | $30 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $120 | $187 | $184 | $154 |
| End Cash | $110 | $120 | $187 | $184 |
| Free Cash Flow | -$62 | -$46 | -$22 | -$24 |